Companies / Reverb Therapeutics
Reverb Therapeutics
Company
Reverb Therapeutics creates medicines that intelligently reshape the body’s immune system to fight cancer and other life-threatening conditions more effectively.
Reverb Therapeutics has 2 investors on file, among them KdT Ventures and Myeloma Investment Fund. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
More from KdT Ventures
61 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (63%), AI & Machine Learning (14%), Food & Agriculture (6%).
More from Myeloma Investment Fund
15 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Myeloma Investment Fund's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Reverb Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when KdT Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/reverbtx.com/investors
# also
GET /v1/companies/reverbtx.com
GET /v1/companies/reverbtx.com/news